Target intelligence / Profile preview

ABL tyrosine kinase (ABL)

Target
ABL
Molecular classification
Enzyme, Nonreceptor tyrosine kinase
01

Overview

The ABL tyrosine kinase, encoded by the *ABL1* gene, is a nonreceptor tyrosine kinase involved in a wide range of cellular processes, including cell proliferation, differentiation, survival, migration, and DNA repair. Its activity is tightly regulated by intramolecular interactions and phosphorylation. Dysregulation, often through chromosomal translocations like t(9;22) leading to the BCR-ABL fusion protein, is a key driver of hematopoietic malignancies such as chronic myelogenous leukemia (CML). Targeting ABL has proven clinically successful, with drugs like imatinib inhibiting aberrant Abl-family kinases.

Other names
ABL1c-Ablv-Abl
02

Mechanism of action

The Abl kinase transfers γ-phosphate from ATP onto specific tyrosines on substrate proteins/peptides. This phosphorylation event alters target protein function—affecting their activity state, cellular location, or interaction networks—which underlies its broad impact on cell fate decisions.

03

Biological functions

Cell proliferationCell differentiationCell survivalCell deathCell migrationCytoskeleton remodelingDNA damage response/repairAntigen receptor signaling in lymphocytesSynapse formation in neuronsBacterial adhesion to epithelial cellsT-cell receptor signaling
04

Disease associations

CancerChronic myelogenous leukemia (CML)Hematopoietic malignancies
05

Interacting drugs

Beyond the preview

Go deeper on ABL tyrosine kinase (ABL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABL tyrosine kinase (ABL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call